Therefore, our discovery here establishing the role of RIP140 in POLK gene regulation not only may explain why POLK is abnormally expressed in cancer, notably in CRC, but can also clarify why cancers cells respond differentially to anticancer genotoxic drugs that target DNA replication forks. Here, NRIP1 is linked to cancer.